Centene lost nearly 1.5 million Medicaid members in 2024, but posted 12% enrollment growth in its marketplace segment, according to the company's fourth quarter earnings report published Feb. 4
Payer
Moody's has revised its outlook for the health insurance sector to negative, citing continually high medical costs that are expected to constrain earnings growth in 2025.
The Cigna Group will tie executive pay to customer satisfaction as part of an initiative to improve members' experiences.
Salt Lake City-based Intermountain Health, through its insurance arm Select Health, rebranded its pharmacy benefit manager to Scripius, a move that highlights the growing trend of health systems bringing PBMs in-house.
In January, some Blue Cross Blue Shield companies planned layoffs and buyouts to combat rising costs.
Insurance CEOs hired police in multiple states to provide security and conduct checks at their homes following the fatal shooting of UnitedHealthcare CEO Brian Thompson in late 2024, the Washington Post reported Jan. 29
Cigna's board of directors declared a $1.51 per share cash dividend to be paid March 20.
A federal judge has partially dismissed a lawsuit filed by a former Johnson & Johnson employee alleging that the pharmaceutical giant mismanaged its employees’ prescription drug benefits, thereby violating its fiduciary duties under the Employee Retirement Income Security Act.
Aetna, Blue Shield of California and Centene's Health Net have launched a shared, value-based payment model for reimbursing primary care physicians in California.
Centene and CVS Health had the highest rates of prior authorization denials in 2023, according to a report from KFF.
